Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · IEX Real-Time Price · USD
45.57
-1.41 (-3.00%)
At close: Jul 19, 2024, 4:00 PM
45.54
-0.03 (-0.07%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Korro Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Korro Bio stock have an average target of 122.5, with a low estimate of 90 and a high estimate of 180. The average target predicts an increase of 168.82% from the current stock price of 45.57.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 21, 2024.
Analyst Ratings
The average analyst rating for Korro Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +119.44% | May 21, 2024 |
BMO Capital | BMO Capital | Buy Maintains $120 | Buy | Maintains | $120 | +163.33% | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $115 → $100 | Strong Buy | Maintains | $115 → $100 | +119.44% | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $115 | Strong Buy | Maintains | $100 → $115 | +152.36% | Mar 28, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $180 | Buy | Maintains | $180 | +295.00% | Mar 27, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-9.83
from -53.08
EPS Next Year
-10.94
from -9.83
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | n/a | n/a |
Avg | n/a | n/a | n/a | n/a | n/a |
Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -9.88 | -10.92 | -10.71 | -10.61 | -11.19 |
Avg | -9.83 | -10.94 | -10.40 | -10.30 | -10.87 |
Low | -9.67 | -10.84 | -10.00 | -9.90 | -10.45 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.